BeStock  
Stocks › Biotechnology › EXEL

Exelixis EXEL

US equityMarket cap rank #1070Biotechnology
$64.63 −$1.20 (-1.82%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $64.63 0.00%
Open$65.95
Prev close$65.83
Day range$64.45 – $66.94
Volume2.19M
Market cap$15.77B
P/E (TTM)19.4
Dividend yield–

EXEL Stock News

Headlines matching Exelixis or the EXEL ticker, most recent first.

  • Truist Financial Maintains Exelixis(EXEL.US) With Hold RatingMarket news · 14 Sep 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: Exelixis (EXEL) and Resolution Minerals Ltd. Sponsored ADR (RML)TipRanks · 14 Sep 2026 · Direct mention
  • BofA Securities Maintains Exelixis(EXEL.US) With Sell Rating, Maintains Target Price $41Market news · 13 Sep 2026 · Direct mention
  • Stifel Maintains Exelixis(EXEL.US) With Hold RatingMarket news · 13 Sep 2026 · Direct mention
  • William Blair Maintains Exelixis(EXEL.US) With Buy RatingMarket news · 11 Sep 2026 · Direct mention
  • Goldman Sachs Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $64Market news · 6 Aug 2026 · Direct mention
  • Truist Financial Maintains Exelixis(EXEL.US) With Hold Rating, Raises Target Price to $56 PositiveMarket news · 7 Jul 2026 · Direct mention
  • Goldman Sachs Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $64 PositiveMarket news · 23 Jul 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (CAI) and Exelixis (EXEL)TipRanks · 2 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $56Market news · 2 Jul 2026 · Direct mention
  • Truist Financial Downgrades Exelixis(EXEL.US) to Hold Rating, Raises Target Price to $54 MixedMarket news · 25 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Kiora Pharmaceuticals (KPRX) and MAIA Biotechnology, Inc. (MAIA)TipRanks · 22 Jun 2026 · Direct mention
  • Stifel Maintains Exelixis(EXEL.US) With Hold Rating, Announces Target Price $47Market news · 7 May 2026 · Direct mention
  • H.C. Wainwright Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $56 PositiveMarket news · 7 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $45 to $55Market news · 6 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on EXEL.

Sign in to join the discussion.

Scroll to Top